[MALAKOF] QoQ TTM Result on 31-Mar-2022 [#1]

Stock
[MALAKOF] MALAKOFF CORPORATION BERHAD
Announcement Date
24-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -3.76%
YoY- -4.99%
Quarter Report
Latest QR
Upcoming QR
MALAKOF's Result
MALAKOF's Financial Summary
View:
Show?
TTM Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 10,355,150 9,326,145 7,729,718 6,995,681 6,463,084 6,033,093 5,932,237 44.82%
PBT 736,771 640,046 477,980 471,066 469,567 479,247 428,248 43.43%
Tax -350,868 -290,489 -180,370 -175,993 -170,352 -151,529 -112,680 112.79%
NP 385,903 349,557 297,610 295,073 299,215 327,718 315,568 14.31%
-
NP to SH 278,431 245,776 246,395 244,984 254,547 286,980 270,622 1.90%
-
Tax Rate 47.62% 45.39% 37.74% 37.36% 36.28% 31.62% 26.31% -
Total Cost 9,969,247 8,976,588 7,432,108 6,700,608 6,163,869 5,705,375 5,616,669 46.44%
-
Net Worth 5,571,179 5,668,919 5,522,309 5,473,440 5,375,700 5,473,440 5,424,570 1.78%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 136,835 136,835 136,835 151,496 151,496 151,496 151,496 -6.54%
Div Payout % 49.15% 55.68% 55.54% 61.84% 59.52% 52.79% 55.98% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 5,571,179 5,668,919 5,522,309 5,473,440 5,375,700 5,473,440 5,424,570 1.78%
NOSH 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 0.00%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 3.73% 3.75% 3.85% 4.22% 4.63% 5.43% 5.32% -
ROE 5.00% 4.34% 4.46% 4.48% 4.74% 5.24% 4.99% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 211.89 190.84 158.17 143.15 132.25 123.45 121.39 44.82%
EPS 5.70 5.03 5.04 5.01 5.21 5.87 5.54 1.91%
DPS 2.80 2.80 2.80 3.10 3.10 3.10 3.10 -6.54%
NAPS 1.14 1.16 1.13 1.12 1.10 1.12 1.11 1.78%
Adjusted Per Share Value based on latest NOSH - 5,000,000
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 211.51 190.49 157.88 142.89 132.01 123.23 121.17 44.82%
EPS 5.69 5.02 5.03 5.00 5.20 5.86 5.53 1.91%
DPS 2.79 2.79 2.79 3.09 3.09 3.09 3.09 -6.56%
NAPS 1.1379 1.1579 1.128 1.118 1.098 1.118 1.108 1.78%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 0.65 0.615 0.63 0.60 0.72 0.815 0.815 -
P/RPS 0.31 0.32 0.40 0.42 0.54 0.66 0.67 -40.09%
P/EPS 11.41 12.23 12.50 11.97 13.82 13.88 14.72 -15.57%
EY 8.77 8.18 8.00 8.35 7.23 7.21 6.79 18.54%
DY 4.31 4.55 4.44 5.17 4.31 3.80 3.80 8.73%
P/NAPS 0.57 0.53 0.56 0.54 0.65 0.73 0.73 -15.16%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 23/02/23 29/11/22 23/08/22 24/05/22 23/02/22 26/11/21 20/08/21 -
Price 0.69 0.645 0.655 0.625 0.705 0.755 0.83 -
P/RPS 0.33 0.34 0.41 0.44 0.53 0.61 0.68 -38.16%
P/EPS 12.11 12.83 12.99 12.47 13.54 12.86 14.99 -13.22%
EY 8.26 7.80 7.70 8.02 7.39 7.78 6.67 15.27%
DY 4.06 4.34 4.27 4.96 4.40 4.11 3.73 5.79%
P/NAPS 0.61 0.56 0.58 0.56 0.64 0.67 0.75 -12.83%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment